Journal Article Gives Insight On Using Personal Preference Information In Clinical Trials
Executive Summary
The FDA has expressed interest in using patient preference information (PPI) to make regulatory decisions for medical devices. A recent article gives recommendations to medical device sponsors who want to study PPI in clinical trials.